medigraphic.com
SPANISH

Medicina Interna de México

Colegio de Medicina Interna de México.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 4

<< Back Next >>

Med Int Mex 2022; 38 (4)

Simultaneous systemic thrombosis as a manifestation of COVID-19

Borges-López JS, Mares-Orozco AR, Barón-Caballero JL, Ayala-Hernández E, Borges-López LM
Full text How to cite this article

Language: Spanish
References: 5
Page: 960-963
PDF size: 229.57 Kb.


Key words:

COVID-19, SARS-CoV-2, Thrombosis, Myocardial infarction.

ABSTRACT

Background: The current COVID-19 pandemic mainly affects the respiratory system; however, with the increase in cases worldwide, there is evidence of compromise at the cardiovascular level, which can manifest as acute myocardial infarction, myocarditis, pericarditis, myopericarditis, heart failure, cardiogenic shock, vasculitis, deep vein thrombosis, pulmonary embolism, ischemic stroke, acute arterial insufficiency, arrhythmias, and sudden death.
Clinical case: A 70-year-old male patient who simultaneously presented multisystemic thrombosis manifested by cerebral vascular event, pulmonary thromboembolism, acute myocardial infarction and acute arterial insufficiency in the context of SARSCoV- 2 pneumonia.
Conclusions: In patients with COVID-19 there is a high thrombogenic potential secondary to blood stasis, hypercoagulability and endothelial dysfunction, which worsens the prognosis and increases mortality, mainly in patients who require ICU stay, so an adequate thromboprophylactic or anticoagulant scheme and follow-up in the convalescent phase must be provided to detect sequelae associated with COVID-19.


REFERENCES

  1. Figueroa-Triana JF, Salas-Márquez DA, Cabrera-Silva JS,Alvarado-Castro CC, Buitrago-Sandoval AF. COVID-19 yenfermedad cardiovascular [COVID-19 and cardiovasculardisease]. Revista Colombiana Cardiología 2020; 27 (3):166-174. doi: 10.1016/j.rccar.2020.04.004.

  2. Fernández A, Barisani JL, Guetta J, Bosio M, et al. COVID-19.Review on its cardiovascular impact. Rev Argent Cardiol2020; 88: 253-274.

  3. Bono JOE, Barcudi R. Daño residual cardiovascular postcovid.Rev Fed Arg Cardiol 2020; 49 (4): 129-132.

  4. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J,Wang X, Lu Z. Cardiovascular implications of fatal outcomesof patients with coronavirus disease 2019 (COVID-19).JAMA Cardiol 2020; 5 (7):811-818. doi: 10.1001/jamacardio.2020.1017.

  5. Atri D, Siddiqi HK, Lang JP, Nauffal V, Morrow DA, BohulaEA. COVID-19 for the cardiologist: Basic virology, epidemiology,cardiac manifestations, and potential therapeuticstrategies. JACC Basic Transl Sci 2020; 5 (5):518-536. doi:10.1016/j.jacbts.2020.04.002.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Med Int Mex. 2022;38